Comparative Effectiveness and Personalized Medicine Research Using Real-World Data (Chapman & Hall/crc Biostatistics Series)

457.78 SGD
会員価格
412.01

Product Description

Comparative effectiveness research has become essential for shaping regulatory policy, informing economic evaluations, and guiding treatment standardization across healthcare systems worldwide. While traditional randomized controlled trials remain the cornerstone of evidence generation, they have important limitations when treatment effects are heterogeneous. In practice, patients often respond differently to the same intervention due to differences in demographics, genetics, comorbidities, and other contextual factors. This variability creates challenges for personalized medicine and limits the generalizability of trial results to diverse real-world patient populations. This comprehensive guide addresses these critical gaps by exploring how real-world data from electronic health records, patient registries, and observational studies can transform comparative effectiveness research and enable truly personalized treatment decisions. Comparative Effectiveness and Personalized Medicine Research Using Real-World Data provides detailed methodological frameworks for moving beyond traditional subgroup analyses to sophisticated approaches that harness the full potential of real-world evidence for individualized patient care. Features Comprehensive coverage of statistical techniques for analyzing heterogeneity of treatment effects and estimating individualized treatment effects Innovative approaches for combining diverse data sources to generate robust comparative effectiveness evidence Cutting-edge algorithms and computational methods for personalized medicine applications Real-world examples, case studies, and vignettes demonstrating successful applications in clinical practice Access to dedicated online training materials, example code, and supplementary content through companion websites Current guidance from FDA, EMA, and other regulatory bodies on real-world evidence in decision-making This text serves as an essential resource for healthcare researchers, biostatisticia

Pivotal to influencing regulatory policies (e.g.,authorization of new drugs), economic evaluations (e.g., reimbursement decisions), and the standardization of care across diverse settings (e.g., through the development of treatment guidelines) for well-functioning healthcare systems.

Available to Order

Usually dispatches within 3-4 weeks

While every attempt has been made to ensure stock availability, occasionally we may run out of stock at our stores.

日本国内への配送は50.00SGD以上のご注文で無料

Discount is applied at checkout.

Recently Viewed Items

Related Products